NCT04308616View on ClinicalTrials.gov

Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Psoriasis
Interventions
OTHER

Blood samples

Blood samples

Trial Locations (1)

37044

Dermatology Service, University Hospital, Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT04308616 - Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis | Biotech Hunter | Biotech Hunter